We are international

A Comprehensive Guide to Torino Multiple Myeloma 2004 Conference
This activity is jointly sponsored by the Institute for Continuing Healthcare Education and the International Myeloma Foundation.

This monograph can be downloaded as an Acrobat PDF document by clicking on the PDF symbol above. You may also request a copy by calling the International Myeloma Foundation at 800-452-2873 (US and Canada), 818-487-7455 (elsewhere) or email us at TheIMF@myeloma.org

INTRODUCTION: These proceedings have been developed based on the 63 presentations given at the live Multiple Myeloma Conference held in Turin, Italy, on April 22–24,2004. Ten expert faculty members, who participated in this conference, have summarized the presentations given by their colleagues and have written a comprehensive overview of the meeting’s scientific sessions. Therefore, these proceedings include the discussion of unlabeled uses of commercial products and/or products that have not yet been approved by the FDA for use in the United States for any purpose. The opinions expressed in this publication are those of the participating faculty and not that of the Institute for Continuing Healthcare Education, the International Myeloma Foundation, or any manufacturers of products mentioned herein. The information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional relative to diagnostic and treatment options of a specific patient’s medical condition. Readers are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosage, and contraindications. This recommendation is particularly important with new or infrequently used products.

CME CREDIT: Readers of this monograph should review all accreditation and disclosure information, learning objectives, and all 10 overviews, including tables, figures, and references. Readers should then complete the post-test, found at the back of this monograph, filling in their answers on the post-test answer key; the registration for credit; and the evaluation form. To receive a certificate of credit, a score of 70% or higher is required on the post-test. This activity is valid until September 30, 2005. It should take approximately 3.5 hours to complete this activity as designed.

Session 1: Molecular Pathogenesis
Brian Van Ness
Minneapolis, Minnesota, USA

Session 2: Phenotype and Functional Abnormalities
Douglas E. Joshua
Sydney, Australia

Session 3: Microenvironment
Ivan Van Riet
Brussels, Belgium

Session 4: Role of Immunosurveillance
Douglas E. Joshua
Sydney, Australia

Session 5: Prognosis
Robert A. Kyle
Rochester, Minnesota, USA

Session 6: Supportive Therapy
Heinz Ludwig
Vienna, Austria

Session 7: Round Table on Autologous Transplantation
Joan Bladé
Barcelona, Spain

Session 8: Round Table on Allogeneic Transplantation
Gösta Gahrton
Stockholm, Sweden

Session 9: New Drugs
Sundar Jagannath
New York, New York, USA

Session 9: New Drugs
Antonio Palumbo
Turin, Italy

Session 10: Immunotherapy
Nikhil C. Munshi
Boston, Massachusetts, USA